A retrospective study of glofitamab salvage therapy for relapsed/refractory B-cell lymphoma in Taiwan
Latest Information Update: 14 Aug 2022
At a glance
- Drugs Glofitamab (Primary) ; Obinutuzumab
- Indications B-cell lymphoma; Diffuse large B cell lymphoma
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 14 Aug 2022 New trial record
- 17 Jun 2022 Results presented at the 27th Congress of the European Haematology Association